CoChat

Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients

Open access
Homicsko, K., Richtig, G., Tuchmann, F., Tsourti, Z., Hanahan, D., Coukos, G., Wind-Rotolo, M., Richtig, E., Zygoura, P., Holler, C., Dafni, U., Michielin, O.A. · 2018 · Annals of Oncology
Cited by 38

The DOI matches its Crossref record.

Abstract

Background: PD1 inhibitors as well as PD1/CTLA4 combinations have shown remarkable efficacy in the first-line treatment of metastatic melanoma. The impact of many concomitant medications on the clinical outcomes from PD1 based therapies remains elusive.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/annonc/mdy511.001

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 38

Metadata

Authors
Homicsko, K., Richtig, G., Tuchmann, F., Tsourti, Z., Hanahan, D., Coukos, G., Wind-Rotolo, M., Richtig, E., Zygoura, P., Holler, C., Dafni, U., & Michielin, O. A.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2018-12
Volume
29
Pages
x40
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2905148438
Cited by
38
References
0
FWCI
1.77
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients. https://app.cochat.ai/papers/10.1093/annonc/mdy511.001
The paper
Homicsko, K., Richtig, G., Tuchmann, F., Tsourti, Z., Hanahan, D., Coukos, G., Wind-Rotolo, M., Richtig, E., Zygoura, P., Holler, C., Dafni, U., & Michielin, O. A. (2018). Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients. Annals of Oncology. https://doi.org/10.1093/annonc/mdy511.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.